Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03853590 · ClinicalTrials.gov registry record · NA
Improvement of Insulin Resistance After Bariatric Surgery
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT03853590 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 42 participants.
The verdict
NCT03853590, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Non-randomized open label study to investigate factors mediating changes in insulin sensitivity, glucose tolerance and other metabolic outcomes after bariatric surgery.
Interventions
- PROCEDURE Roux-en-Y gastric bypass
- PROCEDURE Laparoscopic adjustable gastric banding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-02-25 |
| Est. Completion | 2015-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03853590
The ClinicalTrials.gov registry entry for NCT03853590 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Roux-en-Y gastric bypass is the first listed.
NCT03853590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03853590 about?
NCT03853590 is a clinical study titled "Improvement of Insulin Resistance After Bariatric Surgery". Non-randomized open label study to investigate factors mediating changes in insulin sensitivity, glucose tolerance and other metabolic outcomes after bariatric surgery.
What is the current status of trial NCT03853590?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2010-02-25. Estimated completion is 2015-05-01.
What interventions are being tested in trial NCT03853590?
The interventions under investigation include: Roux-en-Y gastric bypass (PROCEDURE), Laparoscopic adjustable gastric banding (PROCEDURE).
Who is sponsoring clinical trial NCT03853590?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.